Yet another Tour de France winner is entangled in a doping scandal - what a surprise. This time, it is the British rider Bradley Wiggins, who is the subject of a damning report.
His team is accused of supplying Wiggins and his support riders with a banned substance under the guise of medical need. The reality is they have not violated anti-doping rules because the authorities allow so-called Therapeutic Use Exemptions (TUEs).
I addressed this and various issues surrounding anti-doping tests in my book, Numbers Rule Your World, years ago before the Lance Armstrong scandal broke the silence.
TUEs are widely abused in the sports world. For example, the data suggest that either swimming causes asthma, or that people with asthma are much more likely than the general population to engage in world-class competitive swimming.
TUE is a major source of false negatives in the world of anti-doping tests - here, I define false negative as failing to catch a doper, which is broader than dopers passing the anti-doping tests. In the book chapter, I explain why there is very low risk of dopers getting caught by the anti-doping measures.
Comments